XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 50 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |